151 related articles for article (PubMed ID: 28434947)
21. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.
Gomella LG; Mann MJ; Cleary RC; Hubosky SG; Bagley DH; Thumar AB; McCue PA; Lallas CD; Trabulsi EJ
Can J Urol; 2017 Feb; 24(1):8620-8626. PubMed ID: 28263126
[TBL] [Abstract][Full Text] [Related]
22. The Association of A Number of Predictive Factors for The Recurrence of Papillary Urothelial Neoplasm of Low Malignant Potential: Prognostic Analysis From Multiple Academic Centers.
Kim KH; Lee SH; Kim SI; Chung BH; Koo KC; Cho JS; Bang WJ; Park JY; Hong SJ
Urol J; 2019 Dec; 16(6):558-562. PubMed ID: 30882164
[TBL] [Abstract][Full Text] [Related]
23. Neurofuzzy modeling to determine recurrence risk following radical cystectomy for nonmetastatic urothelial carcinoma of the bladder.
Catto JW; Abbod MF; Linkens DA; Larré S; Rosario DJ; Hamdy FC
Clin Cancer Res; 2009 May; 15(9):3150-5. PubMed ID: 19336522
[TBL] [Abstract][Full Text] [Related]
24. The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer.
Meissner C; Giannarini G; Schumacher MC; Thoeny H; Studer UE; Burkhard FC
J Urol; 2007 Dec; 178(6):2287-90. PubMed ID: 17936846
[TBL] [Abstract][Full Text] [Related]
25. Bacillus Calmette-Guérin failure in patients with non-muscle-invasive urothelial carcinoma of the bladder may be due to the urologist's failure to detect urothelial carcinoma of the upper urinary tract and urethra.
Giannarini G; Birkhäuser FD; Recker F; Thalmann GN; Studer UE
Eur Urol; 2014 Apr; 65(4):825-31. PubMed ID: 24144432
[TBL] [Abstract][Full Text] [Related]
26. Increased accuracy of a novel mRNA-based urine test for bladder cancer surveillance.
Pichler R; Fritz J; Tulchiner G; Klinglmair G; Soleiman A; Horninger W; Klocker H; Heidegger I
BJU Int; 2018 Jan; 121(1):29-37. PubMed ID: 28941000
[TBL] [Abstract][Full Text] [Related]
27. Liquid-based cytology as a tool for the performance of uCyt+ and Urovysion Multicolour-FISH in the detection of urothelial carcinoma.
Mian C; Lodde M; Comploj E; Negri G; Egarter-Vigl E; Lusuardi L; Palermo S; Marberger M; Pycha A
Cytopathology; 2003 Dec; 14(6):338-42. PubMed ID: 14632732
[TBL] [Abstract][Full Text] [Related]
28. Outcomes after urothelial recurrence in bladder cancer patients undergoing radical cystectomy.
Mitra AP; Alemozaffar M; Harris BN; Schuckman AK; Skinner EC; Daneshmand S
Urology; 2014 Dec; 84(6):1420-6. PubMed ID: 25306479
[TBL] [Abstract][Full Text] [Related]
29. An institutional experience with The Paris System: A paradigm shift from ambiguous terminology to more objective criteria for reporting urine cytology.
Roy M; Kaushal S; Jain D; Seth A; Iyer VK; Mathur SR
Cytopathology; 2017 Dec; 28(6):509-515. PubMed ID: 28833848
[TBL] [Abstract][Full Text] [Related]
30. Local and systemic recurrence patterns of urothelial cancer after radical cystectomy.
Ozbir S; Girgin C; Kara C; Dinçel C
Kaohsiung J Med Sci; 2014 Oct; 30(10):504-9. PubMed ID: 25438681
[TBL] [Abstract][Full Text] [Related]
31. Follow-up after radical cystectomy based on patterns of tumour recurrence and its risk factors.
Huguet J
Actas Urol Esp; 2013 Jun; 37(6):376-82. PubMed ID: 23611464
[TBL] [Abstract][Full Text] [Related]
32. Comparison of ImmunoCyt, UroVysion, and urine cytology in detection of recurrent urothelial carcinoma: a "split-sample" study.
Sullivan PS; Nooraie F; Sanchez H; Hirschowitz S; Levin M; Rao PN; Rao J
Cancer; 2009 Jun; 117(3):167-73. PubMed ID: 19365828
[TBL] [Abstract][Full Text] [Related]
33. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
34. Comparative diagnostic value of urine cytology, UBC-ELISA, and fluorescence in situ hybridization for detection of transitional cell carcinoma of urinary bladder in routine clinical practice.
May M; Hakenberg OW; Gunia S; Pohling P; Helke C; Lübbe L; Nowack R; Siegsmund M; Hoschke B
Urology; 2007 Sep; 70(3):449-53. PubMed ID: 17688921
[TBL] [Abstract][Full Text] [Related]
35. Ureterorenoscopic biopsy and urinary cytology according to the 2004 WHO classification underestimate tumor grading in upper urinary tract urothelial carcinoma.
Straub J; Strittmatter F; Karl A; Stief CG; Tritschler S
Urol Oncol; 2013 Oct; 31(7):1166-70. PubMed ID: 22300757
[TBL] [Abstract][Full Text] [Related]
36. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma?
Bostwick DG; Hossain D
Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797
[TBL] [Abstract][Full Text] [Related]
37. [Diagnosis and treatment of urethral recurrence after radical cystectomy in the male].
Huguet J
Actas Urol Esp; 2012 Jan; 36(1):42-7. PubMed ID: 21821317
[TBL] [Abstract][Full Text] [Related]
38. Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution?
Giannarini G; Kessler TM; Thoeny HC; Nguyen DP; Meissner C; Studer UE
Eur Urol; 2010 Oct; 58(4):486-94. PubMed ID: 20541311
[TBL] [Abstract][Full Text] [Related]
39. Postoperative bladder washing cytology after transurethral resection. Can it predict the recurrence of urothelial carcinoma?
Iczkowski KA; Katz G; Cascione CJ
Acta Cytol; 2004; 48(3):380-4. PubMed ID: 15192954
[TBL] [Abstract][Full Text] [Related]
40. Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder.
May M; Nitzke T; Helke C; Vogler H; Hoschke B
Scand J Urol Nephrol; 2004; 38(3):231-5. PubMed ID: 15204377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
